Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy

[1]  A. Egashira,et al.  Two-Stage Operation for High-Risk Patients with Thoracic Esophageal Cancer: An Old Operation Revisited , 2011, Annals of Surgical Oncology.

[2]  M. Morita,et al.  In-Hospital Mortality After a Surgical Resection for Esophageal Cancer: Analyses of the Associated Factors and Historical Changes , 2011, Annals of Surgical Oncology.

[3]  M. Morita,et al.  Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery , 2010, Surgery Today.

[4]  A. Sato,et al.  A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). , 2009, Japanese journal of clinical oncology.

[5]  E. Tokunaga,et al.  Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications. , 2009, Anticancer research.

[6]  Y. Tachimori,et al.  Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. , 2009, The Journal of thoracic and cardiovascular surgery.

[7]  Y. Nishimura,et al.  Guidelines for diagnosis and treatment of carcinoma of the esophagus , 2008, Esophagus.

[8]  Y. Nishimura,et al.  Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2007 edition: part I Edited by the Japan Esophageal Society , 2008, Esophagus.

[9]  E. Oki,et al.  Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. , 2008, Surgery.

[10]  E. Oki,et al.  Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[11]  J. Gardner-Thorpe,et al.  Salvage oesophagectomy after local failure of definitive chemoradiotherapy , 2007, The British journal of surgery.

[12]  E. Oki,et al.  Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. , 2007, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[13]  Y. Doki,et al.  Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy , 2006, Journal of surgical oncology.

[14]  K. Hayashi,et al.  Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. , 2004, American journal of surgery.

[15]  H. Kuwano,et al.  Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma , 2004, The British journal of surgery.

[16]  H. Yamana,et al.  Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Yoshida,et al.  Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. , 2003, International journal of radiation oncology, biology, physics.

[18]  M. Posner,et al.  The role of surgery in the management of oesophageal cancer. , 2003, The Lancet. Oncology.

[19]  Narikazu Boku,et al.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Ara A Vaporciyan,et al.  Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. , 2002, The Journal of thoracic and cardiovascular surgery.

[21]  S. Yoshida,et al.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Cooper,et al.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.

[23]  S. Law.  Chemoradiotherapy - panacea for esophageal cancer? Commentary for 'Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)' , 1999 .

[24]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[25]  K. Sugimachi,et al.  Prognostic significance of immunological parameters in patients with esophageal cancer. , 1996, Hepato-gastroenterology.

[26]  M. Stelzner,et al.  Surgical therapy of oesophageal carcinoma , 1990, The British journal of surgery.

[27]  G. Wagner.  The Classification of Malignant Tumors , 1987, Methods of Information in Medicine.

[28]  R. Earlam,et al.  Oesophageal squamous cell carcinoma: II. A critical review of radiotherapy , 1980 .

[29]  R. Earlam,et al.  Oesophogeal squamous cell carcinoms: II. A critical view of radiotherapy. , 1980, The British journal of surgery.

[30]  E. Hjørting-Hansen.  Classification of malignant tumors , 1979 .